UK markets open in 3 hours 20 minutes

NIKKEI 225
38,311.63
+237.65(+0.62%)
HANG SENG
18,817.32
+279.51(+1.51%)
CRUDE OIL
79.76
+0.50(+0.63%)
GOLD FUTURES
2,357.40
+17.10(+0.73%)
DOW
39,387.76
+331.36(+0.85%)
Bitcoin GBP
50,248.12
+1,008.39(+2.05%)

Best UK mortgage deals of the week

As Bank of England holds interest rates, here's what high street banks are offering home buyers

MorphoSys AG (MOR.DE)

XETRA - XETRA Delayed price. Currency in EUR

Add to watchlist

67.00

+0.25

(+0.37%)

At close: 05:35PM CEST

Loading interactive chart…

Business Wire
MorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
Zacks
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.